MILLENNIUM MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 216 filers reported holding DENALI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,441,581
-82.7%
118,351
-75.3%
0.00%
-85.7%
Q2 2023$14,111,269
+158453.6%
478,186
+23.8%
0.01%
+40.0%
Q1 2023$8,900
+7.7%
386,289
+30.0%
0.01%0.0%
Q4 2022$8,262
-99.9%
297,093
-40.1%
0.01%
-44.4%
Q3 2022$15,228,000
-19.8%
496,184
-23.1%
0.01%
-25.0%
Q2 2022$18,992,000
+2218.9%
645,336
+3414.9%
0.01%
Q4 2021$819,000
-61.2%
18,360
-56.1%
0.00%
-100.0%
Q3 2021$2,111,000
-62.5%
41,842
-41.7%
0.00%
-75.0%
Q2 2021$5,627,000
+23.6%
71,743
-10.0%
0.00%0.0%
Q1 2021$4,552,000
-2.6%
79,712
+42.8%
0.00%
+33.3%
Q4 2020$4,675,000
+2.2%
55,814
-56.3%
0.00%
-50.0%
Q3 2020$4,575,000
+748.8%
127,688
+472.4%
0.01%
+500.0%
Q2 2020$539,000
-65.4%
22,309
-78.1%
0.00%
-50.0%
Q3 2019$1,557,000
+94.6%
101,659
+195.1%
0.00%
+100.0%
Q1 2019$800,000
-69.5%
34,451
-80.0%
0.00%
-66.7%
Q2 2018$2,623,000
+77.8%
171,979
+82.3%
0.00%
+50.0%
Q4 2017$1,475,00094,3160.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders